APA

McLaughlin V. V., Gaine S. P., Barst R. J., Oudiz R. J., Bourge R. C., Frost A., Robbins I. M., Tapson V. F., McGoon M. D., Badesch D. B., Sigman J., Roscigno R., Blackburn S. D., Arneson C., Rubin L. J. & Rich S. (20030709). Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. : Journal of cardiovascular pharmacology.

Chicago

McLaughlin Vallerie V, Gaine Sean P, Barst Robyn J, Oudiz Ronald J, Bourge Robert C, Frost Adaani, Robbins Ivan M, Tapson Victor F, McGoon Michael D, Badesch David B, Sigman Jeff, Roscigno Robert, Blackburn Shelmer D, Arneson Carl, Rubin Lewis J and Rich Stuart. 20030709. Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. : Journal of cardiovascular pharmacology.

Harvard

McLaughlin V. V., Gaine S. P., Barst R. J., Oudiz R. J., Bourge R. C., Frost A., Robbins I. M., Tapson V. F., McGoon M. D., Badesch D. B., Sigman J., Roscigno R., Blackburn S. D., Arneson C., Rubin L. J. and Rich S. (20030709). Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. : Journal of cardiovascular pharmacology.

MLA

McLaughlin Vallerie V, Gaine Sean P, Barst Robyn J, Oudiz Ronald J, Bourge Robert C, Frost Adaani, Robbins Ivan M, Tapson Victor F, McGoon Michael D, Badesch David B, Sigman Jeff, Roscigno Robert, Blackburn Shelmer D, Arneson Carl, Rubin Lewis J and Rich Stuart. Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. : Journal of cardiovascular pharmacology. 20030709.